https://www.ubplj.org/index.php/jipp/issue/feedJournal of IP in Practice2025-01-20T16:34:53+00:00University of Buckingham Pressinfo@unibuckinghampress.comOpen Journal Systems<p>The <em>Journal of IP in Practice </em>(JIPP) is published by the University of Buckingham Press (UBP) to fulfil a gap in the market for a publication that is a bridge between detailed research and market commentary and between the academic and commercial sectors. JIPP will be published on an open access basis and is globally distributed.</p> <p>JIPP has an Editorial Board of leading academics and key industry representatives. All research articles will be single-blind peer reviewed and other content carefully reviewed.</p>https://www.ubplj.org/index.php/jipp/article/view/2217Call to Action Industry Article: Start-up IP in Academic Private Sector Partnerships - Who Owns it Really?2024-12-21T10:55:17+00:00Kristine Tkachenkokristine.tkachenko@crowchateau.ca<p>.</p>2025-01-20T00:00:00+00:00Copyright (c) 2024 Kristine Tkachenkohttps://www.ubplj.org/index.php/jipp/article/view/2328Covid Crisis & Patent Waiver – A Saga2024-12-18T17:22:11+00:00Shilpi Mehta Nandashilpi@zealattorneys.com<p>The COVID-19 pandemic has undoubtedly been the biggest calamity in recent times. The pandemic put to test not only the global supply chain and infrastructure but also the national and international disaster-management capacities. These challenging times compelled the world to tackle the problem from a global perspective.</p> <p><br>Ergo, with several joint efforts, the countries were able to collaborate, construct and finally implement an international decision with respect to intellectual property rights, which enabled the world to address the crisis as one.</p> <p><br>In this article, the authors aim to discuss the proposals for intellectual property (IP) / patent waiver and the nuances of WTO’s Ministerial Decision. The authors also highlight the decision’s effectiveness in addressing the issue of the accessibility of resources to combat the dreadful pandemic.</p>2025-01-20T00:00:00+00:00Copyright (c) 2024 Shilpi Mehta Nandahttps://www.ubplj.org/index.php/jipp/article/view/2329OECD BEPS from an IP Management Perspective2024-12-21T11:33:58+00:00Donal O’Connelldonal.oconnell@chawton-ip-solutions.com<p>OECD BEPS has been described as “the most significant re-write of international tax rules in a century”. The essence of OECD BEPS is the switch away from a focus on the legal ownership of the intangible assets (like patents, trademarks, trade secrets, etc.) within a corporate group to a focus on the economic ownership and usage of these intangible assets by the group members. This switch I suggest will have a major impact on IP management and the associated IP policies, IP processes, IP systems, IP data, IP governance, etc. within organizations. These OECD BEPS guidelines are not just about tax, they can be seen as an IP management handbook, dictating how companies should behave when managing their intangible assets.</p>2025-01-20T00:00:00+00:00Copyright (c) 2024 Donal O’Connellhttps://www.ubplj.org/index.php/jipp/article/view/2215AI and Artists: Navigating Ethics, Regulation, and the Impact of AI on Artistic Practice2024-02-16T13:49:29+00:00Reema Selhireema.selhi@dacs.org.uk<p>Advances in Artificial Intelligence (AI) have captured public interest, especially with the advent of generative AI technologies like ChatGPT and Dall-E. These tools, which create text, images, and videos rapidly and often for free, promise transformative impacts on society, economy, and culture. However, for artists, generative AI raises significant practical, ethical, and philosophical questions. A 2023 survey by DACS revealed artists’ concerns about AI’s impact on their work, data privacy, and the spread of misinformation. While some see AI as a positive tool, many demand safeguards and regulations, emphasising the need for consent and compensation when AI uses their work.</p>2025-01-20T00:00:00+00:00Copyright (c) 2024 Reema Selhihttps://www.ubplj.org/index.php/jipp/article/view/2216Expanding Drug Indications: Strategic Lifecycle Management vs. Evergreening in SGLT2 Inhibitors2024-02-16T15:48:58+00:00Kazuhisa Shimmurakazuhisa.shimmura@eucalia.jp<p>In the rapidly evolving pharmaceutical industry, Lifecycle Management (LCM) strategies are critical for maximizing the profitability and extending the market life of drugs. This study investigates the strategic importance of expanding indications for sodium-glucose cotransporter 2 (SGLT2) inhibitors before the expiration of their foundational patents. By analyzing these pre-expiration strategies, the balance between genuine innovation and strategic evergreening is addressed. The analysis covers the legal, regulatory, and clinical dimensions of indication expansions across the US, EU, and Japan, contrasting with the traditional focus on LCM strategies post-patent expiration.</p>2025-01-20T00:00:00+00:00Copyright (c) 2024 Kazuhisa Shimmurahttps://www.ubplj.org/index.php/jipp/article/view/2198Copyright and Generative AI2024-01-19T08:22:51+00:00Thomas Balchcorky@corkybalch.com<p>This is an opinion piece looking at the UK legal copyright framework, human creativity, generative artificial intelligence, and if you need to get permission from the creators or owners of on-line content such as writing, photos, music and film to scrape their content to build AI systems. There is huge concern in the UK’s economically vital and “soft power” driving creative industries, especially when the AI output competes directly with the very content that is used to make the generative AI tool work in the first place. There are essentially two opposing views and this article presents one side.</p>2025-01-20T00:00:00+00:00Copyright (c) 2024 Thomas Balch